Prevalence and Associated Factors of Erectile Dysfunction among Filipino Men with Type 2 Diabetes Mellitus in a Tertiary Hospital in San Juan City, Metro Manila, Philippines
DOI:
https://doi.org/10.15605/jafes.041.02.6147Keywords:
erectile dysfunction, diabetes mellitus, Filipino, prevalenceAbstract
Background. Erectile dysfunction (ED) is a common complication among men with Type 2 Diabetes Mellitus (T2DM), but updated data from the Philippines remain limited. This study determined the prevalence of ED and evaluated associated clinical and socioeconomic factors among Filipino men with T2DM.
Methodology. We conducted a cross-sectional study among 384 adult Filipino men with T2DM recruited from private clinics, an outpatient service clinic, and an affiliated community clinic of Cardinal Santos Medical Center. ED was assessed using the International Index of Erectile Function-5 (IIEF-5). Comparative analyses between participants with and without ED were performed, followed by multivariable logistic regression analysis. Results are presented as adjusted odds ratios (AORs) with 95% confidence intervals (CIs).
Results. The prevalence of erectile dysfunction (ED) among Filipino men with T2DM in this study was 88.02% (338/384; 95% CI: 84.4–91.1). Common comorbidities in the study population included hypertension (67.45%), dyslipidemia (44.53%), and coronary artery disease (26.56%). Regarding glycemic control, only 30.31% of participants had an HbA1c level <7%. Participants with ED were significantly older than those without ED (median age: 60 [IQR 17] vs 48 years [IQR 15], p <0.001) and were more likely to have a longer duration of diabetes. On multivariable analysis, dyslipidemia remained independently associated with higher odds of ED (AOR = 2.57, 95% CI: 1.20–5.53; p = 0.015), whereas higher socioeconomic status was associated with lower odds of ED (AOR = 0.31, 95% CI: 0.13–0.75; p = 0.010).
Conclusion. ED was highly prevalent among Filipino men with T2DM included in this study. Dyslipidemia and socioeconomic status were independently associated with ED and may help identify patients who could benefit from more thorough screening. Further studies involving larger cohorts and improved sampling methods are needed to validate these findings and better understand the factors underlying the high prevalence of ED observed in this population.
Downloads
References
1. Park K, Hwang EC, Kim SO. Prevalence and medical management of erectile dysfunction in Asia. Asian J Androl. 2011;13(4):543-9. https://pubmed.ncbi.nlm.nih.gov/21460862 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739634 https://doi.org/10.1038/aja.2010.131
2. Zhang Y, Zang N, Xiang Y, Lin F, Liu X, Zhang J. A comprehensive analysis of erectile dysfunction prevalence and the impact of prostate conditions on ED among US adults: evidence from NHANES 2001-2004. Front Endocrinol. 2025;15:1412369. https://pubmed.ncbi.nlm.nih.gov/39872316 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11769807 https://doi.org/10.3389/fendo.2024.1412369
3. Yafi FA, Jenkins L, Albersen M, et al. Erectile dysfunction. Nat Rev Dis Primers. 2016;2:16003. https://pubmed.ncbi.nlm.nih.gov/27188339 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027992 https://doi.org/10.1038/nrdp.2016.3
4. Sasayama S, Ishii N, Ishikura F, et al. Men’s health study—Epidemiology of erectile dysfunction and cardiovascular disease. Circ J. 2003;67(8):656-9. https://pubmed.ncbi.nlm.nih.gov/12890904 https://doi.org/10.1253/circj.67.656
5. Binmoammar TA, Hassounah S, Alsaad S, et al. The impact of poor glycaemic control on erectile dysfunction in men with type 2 diabetes mellitus: A systematic review. JRSM Open. 2016;7(3):2054270415622602. https://pubmed.ncbi.nlm.nih.gov/26981254 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776250 https://doi.org/10.1177/2054270415622602
6. Xu Y, Zhang Y, Yang Y, et al. Prevalence and correlates of erectile dysfunction in type 2 diabetic men. Int J Impot Res. 2018;31(1):9-14. https://pubmed.ncbi.nlm.nih.gov/30104671 https://doi.org/10.1038/s41443-018-0060-4
7. Liu Y, Hu X, Xiong M, et al. Association of BMI with erectile dysfunction. Front Endocrinol (Lausanne). 2023;14:1135024. https://pubmed.ncbi.nlm.nih.gov/37065736 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101565 https://doi.org/10.3389/fendo.2023.1135024
8. Vo KT, Huynh HQ, Tran NQ, et al. Prevalence of erectile dysfunction among Vietnamese men with type 2 diabetes. J ASEAN Fed Endocr Soc. 2014. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/111.
9. Fan J, Peng T, Hui J, et al. Erectile dysfunction in type 2 diabetes mellitus patients. Urol Int. 2021;105(11-12):986-92. https://pubmed.ncbi.nlm.nih.gov/33951654 https://doi.org/10.1159/000514700
10. Aytac IA, Araujo AB, Johannes CB, et al. Socioeconomic factors and incidence of erectile dysfunction. Soc Sci Med. 2000;51(5):771-8. https://pubmed.ncbi.nlm.nih.gov/10975236 https://doi.org/10.1016/s0277-9536(00)00022-8
11. Mei Y, Chen Y, Xia W, et al. Social determinants of health and erectile dysfunction. Transl Androl Urol. 2025;14(10):2827-43. https://pubmed.ncbi.nlm.nih.gov/41230153 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12603871 https://doi.org/10.21037/tau-2025-454
12. Zulueta V, Dayahan O, Lansang L. Erectile dysfunction among diabetics. Philipp J Intern Med. 2001;39(5):277-81.
13. Piores OM, Jimeno CA, Trajano-Acampado L. Erectile dysfunction among diabetic men at UP-PGH. Philipp J Intern Med. 2004;42(4):197-202.
14. Maniwang D. Levels of erectile dysfunction in type 2 diabetes. Filip Fam Physician. 2019;57(2):76-80.
15. Rosen RC, Cappelleri JC, Smith MD, et al. Development of the IIEF-5. Int J Impot Res. 1999;11(6):319-26. https://pubmed.ncbi.nlm.nih.gov/10637462 https://doi.org/10.1038/sj.ijir.3900472
16. Gobena MB, Abdosh T, Dheresa M, et al. Erectile dysfunction among patients with diabetes. Front Endocrinol (Lausanne). 2023;14:1131555. https://pubmed.ncbi.nlm.nih.gov/37383399 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294227 https://doi.org/10.3389/fendo.2023.1131555
17. Omar SM, Musa IR, Idrees MB, et al. Erectile dysfunction in men with type 2 diabetes. BMC Endocr Disord. 2022;22(1):141. https://pubmed.ncbi.nlm.nih.gov/35643513 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148516 https://doi.org/10.1186/s12902-022-01060-0
18. Derosa G, Romano D, Tinelli C, et al. Erectile dysfunction in Italian males with T2DM. Diabetes Res Clin Pract. 2015;108(2):329-35. https://pubmed.ncbi.nlm.nih.gov/35464055 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022207 https://doi.org/10.1016/j.diabres.2015.01.037
19. Cordero DA. Male participation in reproductive health care in the Philippines. Am J Mens Health. 2022;16(5). https://pubmed.ncbi.nlm.nih.gov/36154527 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515525 https://doi.org/10.1177/15579883221127559
20. Parmar RS, Verma S, Neelkamal, et al. Prevalence of erectile dysfunction in T2DM. J Fam Med Prim Care. 2022;11(7):3875-9. https://pubmed.ncbi.nlm.nih.gov/36387626 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648286 https://doi.org/10.4103/jfmpc.jfmpc_1130_21
21. Cho NH, Ahn CW, Park JY, et al. Erectile dysfunction in Korean men with T2DM. Diabet Med. 2006;23(2):198-203. https://pubmed.ncbi.nlm.nih.gov/36387626 16433719 https://doi.org/10.1111/j.1464-5491.2005.01789.x
22. Aversa A, Bruzziches R, Francomano D, et al. Endothelial dysfunction and erectile dysfunction. Int J Urol. 2009;17(1):38-47. PMID: 20002226 https://doi.org/10.1111/j.1442-2042.2009.02426.x
23. Bacon CG, Hu FB, Giovannucci E, et al. Diabetes and erectile dysfunction. Diabetes Care. 2002;25(8):1458-63. https://pubmed.ncbi.nlm.nih.gov/12145250 https://doi.org/10.2337/diacare.25.8.1458.
24. Trussell JC, Legro RS. Insulin resistance and erectile dysfunction. Fertil Steril. 2007;88(4):771-8. https://pubmed.ncbi.nlm.nih.gov/17498710 https://doi.org/10.1016/j.fertnstert.2007.01.116
25. Hostnik B, Tonin G, Janez A, et al. Erectile dysfunction in diabetes mellitus. Endocrinol Diabetes Metab. 2025;8(5):e70099. https://pubmed.ncbi.nlm.nih.gov/40960125 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12441930 https://doi.org/10.1002/edm2.70099
26. Bugaevsky KA. Erectile dysfunction: An update. Int J Clin Rep Stud. 2025;4(1). https://doi.org/10.31579/2835-8295/088
27. Montorsi F, Briganti A, Salonia A, et al. Erectile dysfunction and coronary artery disease. Eur Urol. 2003;44(3):360-5. https://pubmed.ncbi.nlm.nih.gov/16422857 https://doi.org/10.1111/j.1743-6109.2005.00084.x
28. Yang B, Cheng H, Hu Y, et al. Effects of anti-diabetic drugs on erectile dysfunction: a systematic review and meta-analysis. Diabetes Metab Syndr Obes. 2025;18:467-78. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11844210 https://pubmed.ncbi.nlm.nih.gov/39990178 https://doi.org/10.2147/DMSO.S503216
29. Feng L, Wang J, Guo S, et al. Causal association between antidiabetic drugs and erectile dysfunction: evidence from Mendelian randomization. Front Endocrinol (Lausanne). 2024;15:1414958. https://pubmed.ncbi.nlm.nih.gov/39247921 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11377246 https://doi.org/10.3389/fendo.2024.1414958
30. Leslie SW, Sooriyamoorthy T. Erectile dysfunction. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK562253/.
31. Hackett GI. Erectile dysfunction and cardiovascular risk. Br J Diabetes. 2016;16(2):52-6. https://doi.org/10.15277/bjd.2016.076
32. Kalter-Leibovici O, Wainstein J, Ziv A, et al. Clinical, socioeconomic, and lifestyle parameters associated with erectile dysfunction among diabetic men. Diabetes Care. 2005;28(7):1739-44. https://pubmed.ncbi.nlm.nih.gov/15983328 Dhttps://doi.org/10.2337/diacare.28.7.1739
33. Huang K, Yin S, Xiao Y, et al. Remnant cholesterol and erectile dysfunction. Lipids Health Dis. 2024;23(1):55. https://pubmed.ncbi.nlm.nih.gov/38388371 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10882869 https://doi.org/10.1186/s12944-024-02046-8
34. Defeudis G, Mazzilli R, Tenuta M, et al. Erectile dysfunction and diabetes. Diabetes Metab Res Rev. 2022;38(2):e3494. https://pubmed.ncbi.nlm.nih.gov/34514697 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286480 https://doi.org/10.1002/dmrr.3494
35. Seid A, Gerensea H, Tarko S, et al. Prevalence and determinants of erectile dysfunction among diabetic patients attending in hospitals of central and northwestern zone of Tigray, northern Ethiopia: a cross-sectional study. BMC Endocr Disord. 2017;17:16. https://pubmed.ncbi.nlm.nih.gov/28298205 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353861 https://doi.org/10.1186/s12902-017-0167-5
36. Macdonald EJ, Gaines JM, Kim JI, et al. Exploring the relationship between socioeconomic status and erectile dysfunction: an analysis of the National Health and Nutrition Examination Survey. Int J Impot Res. 2023;35(5):478-83. https://pubmed.ncbi.nlm.nih.gov/35590043 https://doi.org/10.1038/s41443-022-00584-2
37. Tamrakar D, Bhatt DS, Sharma VK, et al. Association between erectile dysfunction and type 2 diabetes mellitus. J Nepal Health Res Counc. 2021;19(2):378-83 https://pubmed.ncbi.nlm.nih.gov/ 34601534 https://doi.org/10.33314/jnhrc.v19i2.3394
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Joebeth Tabora, Ramon Paolo Abiera, Harold Henrison Chiu, Juan Maria Ibarra Co, Benjamin Ramos Jr., Rosa Allyn Sy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
